John Sperzel

John J.
Sperzel formerly worked at Chembio Diagnostics, Inc., as President, Chief Executive Officer & Director from 2014 to 2017, Chembio Diagnostics, Inc., as President, CEO & Independent Director from 2014 to 2020, ITC Nexus Holding Co., Inc., as Chief Executive Officer from 2011 to 2013, Chembio Diagnostic Systems, Inc., as President, Chief Executive Officer & Director, International Technidyne Corp., as President & Chief Executive Officer from 2011 to 2013, T2 Biosystems, Inc., as Chairman, President & Chief Executive Officer from 2021 to 2025, Diadexus, Inc., as Director, Ontera, Inc., as Director, Bayer Diagnostics Corp., as President-Marketing & Business Development from 2000 to 2009, Axis-Shield Ltd., as President-USA, and Roche Diagnostics Corp., as Vice President from 1987 to 1997.
Mr. Sperzel received his undergraduate degree from Plymouth State University.